Heptavalent Botulism Antitoxin (HBAT)

URI: https://gptkb.org/entity/Heptavalent_Botulism_Antitoxin_(HBAT)
GPTKB entity
Statements (33)
Predicate Object
gptkbp:instanceOf antitoxin
gptkbp:administeredBy intravenous infusion
gptkbp:antibodySource horse plasma
gptkbp:antibodyType F(ab')2 fragments
gptkbp:approvalYear 2013
gptkbp:approvedBy gptkb:U.S._Food_and_Drug_Administration
gptkbp:compatibleWith infants younger than 1 year
gptkbp:contains equine-derived antibodies
gptkbp:developedBy gptkb:Cangene_Corporation
gptkbp:distributedBy gptkb:Centers_for_Disease_Control_and_Prevention
https://www.w3.org/2000/01/rdf-schema#label Heptavalent Botulism Antitoxin (HBAT)
gptkbp:neutralizes gptkb:botulinum_neurotoxin_types_F
botulinum neurotoxin types A
botulinum neurotoxin types B
botulinum neurotoxin types C
botulinum neurotoxin types D
botulinum neurotoxin types E
botulinum neurotoxin types G
gptkbp:replacedBy gptkb:Botulism_Antitoxin_Types_A,_B,_and_E_(BAT-ABE)
gptkbp:sideEffect fever
nausea
vomiting
headache
allergic reaction
chills
rash
serum sickness
gptkbp:treatment botulism
gptkbp:usedFor adults
children
infants older than 1 year
gptkbp:bfsParent gptkb:Botulism_Antitoxin
gptkbp:bfsLayer 7